Logo image of OPAD

OFFERPAD SOLUTIONS INC (OPAD) Stock Fundamental Analysis

NYSE:OPAD - US67623L3078 - Common Stock

1.54 USD
+0.2 (+14.93%)
Last: 8/22/2025, 8:04:01 PM
1.93 USD
+0.39 (+25.32%)
After Hours: 8/22/2025, 8:04:01 PM
Fundamental Rating

2

Taking everything into account, OPAD scores 2 out of 10 in our fundamental rating. OPAD was compared to 64 industry peers in the Real Estate Management & Development industry. OPAD has a bad profitability rating. Also its financial health evaluation is rather negative. OPAD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OPAD had negative earnings in the past year.
In the past year OPAD had a positive cash flow from operations.
OPAD had negative earnings in 4 of the past 5 years.
In multiple years OPAD reported negative operating cash flow during the last 5 years.
OPAD Yearly Net Income VS EBIT VS OCF VS FCFOPAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

1.2 Ratios

OPAD has a Return On Assets of -21.20%. This is in the lower half of the industry: OPAD underperforms 76.56% of its industry peers.
Looking at the Return On Equity, with a value of -231.60%, OPAD is doing worse than 79.69% of the companies in the same industry.
Industry RankSector Rank
ROA -21.2%
ROE -231.6%
ROIC N/A
ROA(3y)-22.91%
ROA(5y)-14.91%
ROE(3y)-122.51%
ROE(5y)-74.49%
ROIC(3y)N/A
ROIC(5y)N/A
OPAD Yearly ROA, ROE, ROICOPAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

With a Gross Margin value of 8.32%, OPAD is not doing good in the industry: 70.31% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of OPAD has declined.
OPAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5YN/A
OPAD Yearly Profit, Operating, Gross MarginsOPAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

2

2. Health

2.1 Basic Checks

OPAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OPAD has more shares outstanding
Compared to 1 year ago, OPAD has a worse debt to assets ratio.
OPAD Yearly Shares OutstandingOPAD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
OPAD Yearly Total Debt VS Total AssetsOPAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.17, we must say that OPAD is in the distress zone and has some risk of bankruptcy.
OPAD has a Altman-Z score of -0.17. This is in the lower half of the industry: OPAD underperforms 70.31% of its industry peers.
The Debt to FCF ratio of OPAD is 5.01, which is a neutral value as it means it would take OPAD, 5.01 years of fcf income to pay off all of its debts.
OPAD has a better Debt to FCF ratio (5.01) than 76.56% of its industry peers.
A Debt/Equity ratio of 8.80 is on the high side and indicates that OPAD has dependencies on debt financing.
OPAD has a Debt to Equity ratio of 8.80. This is amonst the worse of the industry: OPAD underperforms 82.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.8
Debt/FCF 5.01
Altman-Z -0.17
ROIC/WACCN/A
WACC9.1%
OPAD Yearly LT Debt VS Equity VS FCFOPAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

2.3 Liquidity

OPAD has a Current Ratio of 1.09. This is a normal value and indicates that OPAD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of OPAD (1.09) is worse than 64.06% of its industry peers.
OPAD has a Quick Ratio of 1.09. This is a bad value and indicates that OPAD is not financially healthy enough and could expect problems in meeting its short term obligations.
OPAD has a Quick ratio of 0.16. This is amonst the worse of the industry: OPAD underperforms 90.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.16
OPAD Yearly Current Assets VS Current LiabilitesOPAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

OPAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.57%, which is quite good.
Looking at the last year, OPAD shows a very negative growth in Revenue. The Revenue has decreased by -30.44% in the last year.
The Revenue for OPAD have been decreasing by -23.72% on average. This is quite bad
EPS 1Y (TTM)15.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22%
Revenue 1Y (TTM)-30.44%
Revenue growth 3Y-23.72%
Revenue growth 5YN/A
Sales Q2Q%-36.16%

3.2 Future

The Earnings Per Share is expected to grow by 25.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.49% on average over the next years. This is quite good.
EPS Next Y27.9%
EPS Next 2Y27.93%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue Next Year-13.37%
Revenue Next 2Y10.44%
Revenue Next 3Y10.17%
Revenue Next 5Y19.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPAD Yearly Revenue VS EstimatesOPAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
OPAD Yearly EPS VS EstimatesOPAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OPAD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPAD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPAD Price Earnings VS Forward Price EarningsOPAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

OPAD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OPAD is cheaper than 98.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.09
EV/EBITDA N/A
OPAD Per share dataOPAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as OPAD's earnings are expected to grow with 25.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.93%
EPS Next 3Y25.56%

More info and screens

0

5. Dividend

5.1 Amount

OPAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OFFERPAD SOLUTIONS INC

NYSE:OPAD (8/22/2025, 8:04:01 PM)

After market: 1.93 +0.39 (+25.32%)

1.54

+0.2 (+14.93%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03
Inst Owners57.37%
Inst Owner Change-2.51%
Ins Owners15.39%
Ins Owner Change2.5%
Market Cap47.09M
Analysts48.89
Price Target1.21 (-21.43%)
Short Float %5.32%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.42%
Min EPS beat(2)0.15%
Max EPS beat(2)0.69%
EPS beat(4)2
Avg EPS beat(4)-9.26%
Min EPS beat(4)-28.68%
Max EPS beat(4)0.69%
EPS beat(8)2
Avg EPS beat(8)-16.09%
EPS beat(12)4
Avg EPS beat(12)-23.57%
EPS beat(16)7
Avg EPS beat(16)0.97%
Revenue beat(2)0
Avg Revenue beat(2)-12.43%
Min Revenue beat(2)-12.72%
Max Revenue beat(2)-12.15%
Revenue beat(4)0
Avg Revenue beat(4)-6.78%
Min Revenue beat(4)-12.72%
Max Revenue beat(4)-0.3%
Revenue beat(8)1
Avg Revenue beat(8)-5.77%
Revenue beat(12)5
Avg Revenue beat(12)1.76%
Revenue beat(16)8
Avg Revenue beat(16)3.62%
PT rev (1m)13.33%
PT rev (3m)-42.98%
EPS NQ rev (1m)-0.76%
EPS NQ rev (3m)7.69%
EPS NY rev (1m)0%
EPS NY rev (3m)4.48%
Revenue NQ rev (1m)-38.55%
Revenue NQ rev (3m)-49.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF 1.09
P/OCF 0.95
P/B 1.91
P/tB 1.91
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)1.42
FCFY91.98%
OCF(TTM)1.62
OCFY105.06%
SpS23.14
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.2%
ROE -231.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.32%
FCFM 6.12%
ROA(3y)-22.91%
ROA(5y)-14.91%
ROE(3y)-122.51%
ROE(5y)-74.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5YN/A
F-Score4
Asset Turnover2.62
Health
Industry RankSector Rank
Debt/Equity 8.8
Debt/FCF 5.01
Debt/EBITDA N/A
Cap/Depr 810.19%
Cap/Sales 0.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.16
Altman-Z -0.17
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)337.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22%
EPS Next Y27.9%
EPS Next 2Y27.93%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.44%
Revenue growth 3Y-23.72%
Revenue growth 5YN/A
Sales Q2Q%-36.16%
Revenue Next Year-13.37%
Revenue Next 2Y10.44%
Revenue Next 3Y10.17%
Revenue Next 5Y19.49%
EBIT growth 1Y33.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.8%
EBIT Next 3Y34.97%
EBIT Next 5Y20.79%
FCF growth 1Y-94.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.77%
OCF growth 3YN/A
OCF growth 5YN/A